Replies to post #146358 on Biotech Values

[DewDiligence]

…your math with PFE needs a little work as you compare your "annualized" emerging market to the 2Q12 sales results of PFE.

My arithmetic is fine. I said PFE had annualized sales of $10.5B in 2Q12, and they did: $2.62B x4 = $1.048B, which rounds to $10.5B.

As noted in #msg-78051550, $10.5B is hardly the “small base” you claimed it was in your previous post. It’s more than the entire annual sales of all but a few drug/biotech companies.